Manage your child's medical information and connect with your Arkansas Children's medical team online.
Login Sign upArkansas Children's Hospital
General Information 501-364-1100
Arkansas Children's Northwest
General Information 479-725-6800
A Phase I/II, Multicenter, Open-Label, Multi-Arm Study Evaluating the Safety, Tolerability in Combination with Either Chemotherapy or Venetoclax in the Treatment of Pediatric and Young Adult Patients with Relapsed/Refractory Acute Leukemias or Solid Tumors
This study is a phase I/IIa study of 2-Hydroxyoleic acid in pediatric patients with malignant glioma and other advanced solid tumors.
The purpose of this study is to find out what effects study treatment with talazoparib in combination with conventional chemotherapy agents topotecan and gemcitabine has on you and your cancer.
The purpose of this study is to provide OKN-007 for compassionate use in patients with diffuse midline glioma, H3 K27-altered (DMG), including diffuse intrinsic pontine glioma (DIPG) and collect sufficient information about the patient’s treatment.